OXA-23-producing Acinetobacter species from horses: A public health hazard?

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 12, 2012, Pages 3009-3010

  Smet, Annemieke ^a   Boyen, Filip ^a   Pasmans, Frank ^a   Butaye, Patrick ^a,b   Martens, Ann ^a   Nemec, Alexandr ^c   Deschaght, Pieter ^a   Vaneechoutte, Mario ^a   Haesebrouck, Freddy ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

Animals; Carbapenemases; Insertion sequences

Indexed keywords

AGAR; CARBAPENEM; CARBAPENEMASE; CEFQUINOME; IMIPENEM; PEPTONE; PROCAINE PENICILLIN; RNA 16S;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; FECES ANALYSIS; GRAM NEGATIVE BACTERIUM; HEALTH HAZARD; HORSE; HOSPITALIZATION; HYDROLYSIS; INCUBATION TEMPERATURE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; PUBLIC HEALTH; START CODON; SURGICAL DRAINAGE; WOUND INFECTION;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANIMALS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; DNA TRANSPOSABLE ELEMENTS; HORSE DISEASES; HORSES; MICROBIAL SENSITIVITY TESTS;

EID: 84869405173     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks311     Document Type: Letter

References (10)

1. Mugnier PD, Poirel L, Naas T et al. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010; 16: 35-40.
2. Poirel L, Berçot B, Milleman Y et al. Carbapenemaseproducing Acinetobacter spp. in cattle, France. Emerg Infect Dis 2012; 18: 523-4.
3. Cruze JA, Singer JT, Finnerty WR. Conditions for quantitative transformation in Acinetobacter calcoaceticus. Curr Microbiol 1979; 3: 129-32.
4. Nemec A, Krizova L, Maixnerova M et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011; 162: 393-404.
5. Smet A, Martel A, Persoons D et al. Diversity of extended-spectrum b-lactamases and class C b-lactamases among cloacal Escherichia coli in Belgian broiler farms. Antimicrob Agents Chemother 2008; 52: 1238-43.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA, 2012.
7. Corvec S, Poirel L, Naas T et al. Genetics and expression of the carbapenem-hydrolysing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 1530-3.
8. Boo TW, Walsh F, Crowley B. Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3. J Med Microbiol 2009; 58: 209-16.
9. Zhu Z, Du X, Wang L et al. Clinical carbapenem-resistant Acinetobacter baylyi strain coharboring blaSIM-1 and blaOXA-23 from China. Antimicrob Agents Chemother 2011; 55: 5347-9.
10. Vaneechoutte M, Devriese LA, Dijkshoorn L et al. Acinetobacter baumannii-infected vascular catheters collected from horses in an equine clinic. J Clin Microbiol 2000; 38: 4280-1.